<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) in 142 patients with thryotoxicosis was 21% and that of <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> was 8.5% </plain></SENT>
<SENT sid="1" pm="."><plain>Male sex, increasing age, and associated rheumatic or <z:e sem="disease" ids="C0152105" disease_type="Disease or Syndrome" abbrv="">hypertensive heart disease</z:e> were significantly associated with the presence of AF </plain></SENT>
<SENT sid="2" pm="."><plain>Thromboembolic episodes occurred in 12 (40%) of the patients with AF and in none of the 112 patients without AF </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">Cerebral emboli</z:e> accounted for 53% of the episodes </plain></SENT>
<SENT sid="4" pm="."><plain>In view of the grave prognosis of the embolic episodes, patients with <z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">thyrotoxicosis</z:e> should be treated with <z:chebi fb="5" ids="28304">heparin</z:chebi> during attacks of AF and with oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> when they have <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0006109'>fibrillation</z:mp> </plain></SENT>
</text></document>